Xience nano Everolimus Eluting Coronary Stent System regulatory update

Abbott said FDA approved its Xience nano Everolimus Eluting Coronary Stent System to treat coronary artery disease (CAD) in vessels as small as 2.25 mm in diameter. The stent, which utilizes a durable...